Invention Grant
US08168762B2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
有权
抗原结合蛋白与蛋白转化酶枯草杆菌蛋白酶Kexin 9型（PCSK9）
- Patent Title: Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
- Patent Title (中): 抗原结合蛋白与蛋白转化酶枯草杆菌蛋白酶Kexin 9型（PCSK9）
-
Application No.: US13251955Application Date: 2011-10-03
-
Publication No.: US08168762B2Publication Date: 2012-05-01
- Inventor: Simon Mark Jackson , Bei Shan , Wenyan Shen , Chadwick Terence King
- Applicant: Simon Mark Jackson , Bei Shan , Wenyan Shen , Chadwick Terence King
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: C07K16/26
- IPC: C07K16/26 ; C07K16/00
Abstract:
Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
Public/Granted literature
- US20120020976A1 ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) Public/Granted day:2012-01-26
Information query
